Goldman Sachs’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-73,980
| Closed | -$3.2M | – | 4787 |
|
|
2015
Q3 | $3.2M | Buy |
73,980
+47,623
| +181% | +$2.06M | ﹤0.01% | 2274 |
|
|
2015
Q2 | $1.11M | Sell |
26,357
-32,529
| -55% | -$1.37M | ﹤0.01% | 2901 |
|
|
2015
Q1 | $2.28M | Sell |
58,886
-2,563
| -4% | -$99.4K | ﹤0.01% | 2471 |
|
|
2014
Q4 | $2.07M | Buy |
61,449
+15,130
| +33% | +$509K | ﹤0.01% | 2480 |
|
|
2014
Q3 | $1.62M | Buy |
46,319
+37,043
| +399% | +$1.3M | ﹤0.01% | 2623 |
|
|
2014
Q2 | $305K | Buy |
9,276
+2,667
| +40% | +$87.7K | ﹤0.01% | 3681 |
|
|
2014
Q1 | $244K | Buy |
+6,609
| New | +$244K | ﹤0.01% | 3807 |
|
|
2013
Q4 | – | Sell |
-9,665
| Closed | -$265K | – | 4396 |
|
|
2013
Q3 | $265K | Buy |
+9,665
| New | +$265K | ﹤0.01% | 3690 |
|